EspaƱol
ABOUT US | CONTACT | VOLUNTEER
MISSION & MINISTRY
Find a Physician
Decrease (-) Restore Default Increase (+)

Emanuel News, Classes & Events, Health Headlines

Print this page     Email to a friend

Clinical Trials Update: Jan. 17, 2011

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Influenza (Ages 1 and Older)

Candidates for this study must have had flu-like symptoms that started in the past 48 hours.

The research site is in Topeka, Kan.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/influenza.aspx.

-----

Gout and Cardiovascular Disease

This study will evaluate the cardiovascular safety of febuxostat compared to allopurinol in people who have both gout and cardiovascular problems.

The research site is in Pinellas Park, Fla.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.

-----

Type 2 Diabetes

This study will evaluate new treatment options for type 2 diabetes. Participants, who must be aged 18 to 70, will receive study-related investigational medication, physical and laboratory tests, and compensation for time and travel.

The research site is in Gurnee, Ill.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.

-----

Copyright 2011 ClinicalConnection.com. All rights reserved.


Copyright © 2011 HealthDay. All rights reserved.

About Us



Emanuel Cancer Centers 2013 Annual Report
Joint Notice of Privacy Practices
Accreditation & Quality Measures
Board of Directors
CEO's Message
Community Crisis Information
Maps & Directions
Mission & Ministry
News & Publications
Volunteer

Care & Services



Emanuel Physician Finder

Employees & Physicians



e-MC Physician Portal
Web Mail
Employment Services
Physician Verification
Living in Turlock
Contact Us

Emanuel Medical Center
825 Delbon Avenue
Turlock, CA 95382
(209) 667-4200
Contact Us
© 2014 Emanuel Medical Center, Inc. All rights reserved
Home   |   Site Map   |   Joint Notice of Privacy Practices